Bristol Myers Squibb Vs. AbbVie Stock
Given its better valuation, we believe that Bristol Myers Squibb stock (NYSE: BMY) is currently a better pick than its peer – ...
Sell Rating on Bristol-Myers Squibb Amid Competitive Pressures and Pricing Concerns
In a report released yesterday, Carter Gould from Barclays maintained a Sell rating on Bristol-Myers Squibb (BMY – Research Report), with ...
FiercePharma1d
Citing enrollment challenges, Bristol Myers and 2seventy scrap Abecma trial in first-line myeloma
Bristol Myers Squibb’s struggling CAR-T therapy Abecma has hit a major setback. | Bristol Myers Squibb’s CAR-T therapy Abecma ...
Merck, Bristol-Myers fail to convince FDA AdCom on wider Opdivo, Keytruda use
An FDA expert panel on Thursday voted against a broader use of Merck (MRK) and Bristol-Myers (BMY) immune checkpoint inhibitors Keytruda and Opdivo. Read more here.
Treasury15h
BMS Breaks Free from the Captivity of an Inefficient Insurance Structure
Congratulations to Bristol Myers Squibb on winning the 2024 Silver Alexander Hamilton Award in Operational Risk Management & ...
Bristol-Myers Squibb Company (BMY): Among the Dividend Giants with Lowest Short Interest in 2024
We recently compiled a list of the 8 Dividend Giants with Lowest Short Interest in 2024. In this article, we are going to ...
Petri Dish: 2seventy, BMS halt Phase 3 trial; Flagship spinout names CSO
Inc. and Bristol Myers Squibb halted a Phase 3 trial, the Healey-Driscoll administration has announced nearly $20 million in ...
ABC71d
Bristol Myers Squibb Employees Bike 3,000 Miles Cross-Country To Fundraise for Cancer Research
To help battle cancer and fund cancer research, Bristol Myers Squibb employees bike from Oregon to New Jersey to raise $1 ...